MEDLINEPLUS.GOV : www.medlineplus.gov - 237 in TOP 100 MEDICAL SITES. Rating: 14100.

Most popular searches: MedlinePlus, www.edlineplus.gov, ww.medlineplus.gov, www.medlinepus.gov, www.mdlineplus.gov, Dictionaries, www.medlinepls.gov, www.medlineplus.ov, www.medlineplus.gvo, www.medlineplu.gov, ww.wmedlineplus.gov, www.medlinelpus.gov, Featured Health Site, www.medlineplu.sgov, www.medlineplus.gov, Clinical Trials, wwwm.edlineplus.gov, Other Resources, www.medlineplus.gvo, www.medlinplus.gov, www.medlinelus.gov, Drugs and Supplements , Health Information, National Library of Medicine, www.medlinpelus.gov, www.meldineplus.gov, www.medlienplus.gov, www.melineplus.gov, www.medlineplusgov, wwwmedlineplus.gov, National Institutes of Health, www.medlineplsu.gov, www.medlineplus.gv, wwwmedlineplus.gov, www.medlineplus.com, www.medlineplus.go, www.medilneplus.gov, Health News, Directories, NIHSeniorHealth, www.medlneplus.gov, www.mdelineplus.gov, www.medlineplus.ogv, www.medineplus.gov, clinicaltrials.gov, Interactive Tutorials, ww.medlineplus.gov, www.medlieplus.gov, www.medlineplus.gov, www.medlinepuls.gov, www.medlineplusg.ov, www.emdlineplus.gov, www.medlnieplus.gov

Heart Devices Reduce Hospitalization
Final results from an industry-funded study of medical implants that slow heart deterioration found benefits more pronounced than in a preliminary analysis in June.
sec.online.wsj.com

Biden Focuses on Health Premiums
Biden said new data showing health-insurance premiums rising faster in every state than wages or inflation highlight the need for health-care legislation.
online.barrons.com

Novartis Highlights New Drug Tasigna
Novartis said its leukemia drug Tasigna worked better than the company's older product Gleevec in a clinical trial, underpinning expectations that Novartis is positioning Tasigna to replace Gleevec when the latter drug loses patent protection in 2015.
online.wsj.com

Limited Effect Seen in Abortion Clause
Restrictions on abortion coverage approved in the House version of the health-care bill likely will affect the affordability of the procedure for only a small minority of women.
online.wsj.com

Neogen Beats by a Penny
Zacks.com submits: Neogen Corp. (NEOG) recently posted fiscal second quarter results. The company’s GAAP net income grew 18% to $4.6 million, compared to $3.9 million in the year-ago period. Adjusting for a 3-for-2 stock split effective Dec 15, earnings per share came in at 20 cents per share, which edged past the Zacks Consensus Estimate by a penny. Neogen develops and markets products dedicated to food and animal safety. The company's Food Safety division markets dehydrated culture media, and diagnostic test kits to detect food borne bacteria, natural toxins, genetic modifications, food allergens, drug residues, plant diseases and sanitation concerns. Neogen's Animal Safety division markets a complete line of diagnostics, veterinary instruments, veterinary pharmaceuticals, nutritional supplements, disinfectants, and rodenticides. During the quarter, Neogen completed the acquisition of BioKits food safety business of Gen-Probe Inc. (GPRO). The U.K.-based business includes more than 50 test kits for food allergens, meat and fish speciation, and plant genetics.Complete Story »
seekingalpha.com